Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr·2018·International Journal of Molecular Sciences
DOI 10.3390/ijms19071884

Cites (230)

Items 201–228 of 228

  1. Reduced levels of the tyrosine phosphatase STEP block beta amyloid‐mediated GluA1/GluA2 receptor internalization
    Yongfang Zhang, Pradeep K. Kurup, Jian Xu, George M. Anderson, Paul Greengard, Angus Clark Nairn, Paul J. Lombroso · 2011 · Journal of Neurochemistry
  2. Aβ42 oligomers selectively disrupt neuronal calcium release
    Cristian Lazzari, Maulilio John Kipanyula, Mario Agostini, Tullio Pozzan, Cristina Fasolato · 2014 · Neurobiology of Aging
  3. Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer′s disease mice
    Peng Zhao, Gaoshang Chai, Yangyang Wang, Amina Yasheng · 2016 · Neural Regeneration Research
  4. Age-related loss of noradrenergic neurons in the brains of triple transgenic mice
    Manaye, Kebreten F., Mouton, Peter R., Xu, Guang, Drew, Amy, Lei, De-Liang, Sharma, Yukti, Rebeck, G. William, Turner, Scott · 2013 · AGE
  5. Synaptic Plasticity Defect Following Visual Deprivation in Alzheimer's Disease Model Transgenic Mice
    Christopher M. William, Mark L. Andermann, Glenn J. Goldey, Demetris K. Roumis, R. Clay Reid, Carla J. Shatz, Mark W. Albers, Matthew P. Frosch, Bradley T. Hyman · 2012 · Journal of Neuroscience
  6. Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.
    Nan-Nan Yu, Xiang-Xiang Wang, Jin-Tai Yu, Nai-dong Wang, Rui-Chun Lu, Dan Miao, Yan Tian, L. Tan · 2010 · Brain Research
  7. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer’s disease: A potential therapeutic target?
    Parmi Patel, Jigna Shah · 2017 · Journal of Chemical Neuroanatomy
  8. Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated guanylate kinase (MAGUK) proteins
    Mårten Larsson, Göran Hjälm, Amos M. Sakwe, Åke Engström, Anna-Stina Höglund, Erik Larsson, Robert Charles Robinson, Christian Sundberg, Lars Rask · 2003 · Biochemical Journal
  9. Activation of β‐adrenergic receptors facilitates heterosynaptic translation‐dependent long‐term potentiation
    Steven A. Connor, Yu Tian Wang, Peter Nguyen · 2011 · The Journal of Physiology
  10. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation
    Erin Bove‐Fenderson, Ryo Urano, John E. Straub, David A. Harris · 2017 · Journal of Biological Chemistry
  11. Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology
    Andrea F.N. Rosenberger, Annemieke J.M. Rozemüller, Wiesje M. van der Flier, Philip Scheltens, Saskia M. van der Vies, Jeroen J.M. Hoozemans · 2014 · Acta Neuropathologica Communications
  12. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer’s-Associated Aβ Oligomers
    Kyle C. Wilcox, Matthew R. Marunde, Aditi Das, Pauline T. Velasco, Benjamin D. Kuhns, Michael Thomas Marty, Jiang Haoming, Chi-Hao Luan, Stephen G. Sligar, William L. Klein · 2015 · PLoS ONE
  13. The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of β-amyloid
    Claudio Costantini, Vittorina Della Bianca, Elena Formaggio, Cristiano Chiamulera, Alessio Montresor, Filippo Rossi · 2005 · Experimental Cell Research
  14. Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
    Miyamoto, Takashi, Kim, Daniel, Knox, Joseph A., Johnson, Erik, Mucke, Lennart · 2016 · Journal of Biological Chemistry
  15. Diet and Nutrition Reverse Type 3 Diabetes and Accelerated Aging Linked to Global Chronic Diseases
    Ian James Martins · 2016 · Journal of Diabetes Research and Therapy
  16. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies
    Dainan Zhang, Yingjie Qi, Igor V. Klyubin, Tomáš Ondrejčák, Claire J. Sarell, A. Claudio Cuello, John Collinge, Michael J. Rowan · 2017 · Neuropharmacology
  17. Role of cellular prion protein in interneuronal amyloid transmission
    José Antonio del Rı́o, Isidró Ferrer, Rosalina Gavı́n · 2018 · Progress in Neurobiology
  18. Memantine inhibits β-amyloid aggregation and disassembles preformed β-amyloid aggregates
    Kaori Ito‐Takahashi, Mitsuhiro Makino, Keiko Okado, Taisuke Tomita · 2017 · Biochemical and Biophysical Research Communications
  19. Involvement of Insulin-Like Growth Factor 1 Receptor Signaling in the Amyloid-β Peptide Oligomers-Induced p75 Neurotrophin Receptor Protein Expression in Mouse Hippocampus
    Shingo Ito, Michel Ménard, Trevor G. Atkinson, Chantal Gaudet, Leslie Brown, James Whitfield, Balu Chakravarthy · 2012 · Journal of Alzheimer s Disease
  20. Restoring long-term potentiation impaired by amyloid-beta oligomers: Comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists
    Katja S. Kroker, Jens Moreth, Lothar Kußmaul, Georg F. Rast, Holger Rosenbrock · 2013 · Brain Research Bulletin
  21. The kinase activity of EphA4 mediates homeostatic scaling-down of synaptic strength via activation of Cdk5
    Yi‐Rong Peng, Zai-Hua Hou, Xiang Yu · 2012 · Neuropharmacology
  22. Plant metal chaperones: a novel perspective in dementia therapy
    Bernd Kastenholz, David E. Garfin, Jürgen Horst, KERSTIN A. NAGEL · 2009 · Amyloid
  23. Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease
    Jingyi Liang, Don Kulasiri, Sandhya Samarasinghe · 2017 · PLoS ONE
  24. Axon regeneration impediment: the role of paired immunoglobulin-like receptor B
    Jing Liu, Yan Wang, Wei Fu · 2015 · Neural Regeneration Research
  25. The identification of a novel isoform of EphA4 and ITS expression in SOD1 G93A mice
    Jing Zhao, Andy Boyd, Perry F. Bartlett · 2017 · Neuroscience
  26. The amyloid cascade is not the only pathway to AD
    Gaël Chételat · 2013 · Nature Reviews Neurology
  27. Ephs and ephrins: Emerging therapeutic targets in neuropathology
    Benjamin K. Attwood, Satyam Patel, Robert Pawlak · 2012 · The International Journal of Biochemistry & Cell Biology
  28. Can tauopathy shake the amyloid cascade hypothesis?
    Venugopalan Y. Vishnu · 2013 · Nature Reviews Neurology